Table 3 Drug provocation test results in patients from Group A (Good tolerance to cefadroxil) and Group B (Cross-reactivity with cefadroxil)
From: Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes
Pat | Group | Drug | Reaction | IDR (min) | TCD (mg) |
|---|---|---|---|---|---|
1 | A | AX | Urticaria | 160 | 500 |
PV/CX/CO | Good tolerance | – | – | ||
2 | B | PV/CO | Good tolerance | – | – |
3 | A | PV/CX/CO | Good tolerance | – | – |
4 | B | PV/CO | Good tolerance | – | – |
5 | A | AX | Anaphylaxis | 15 | 50 |
PV/CX/CO | Good tolerance | – | – | ||
6 | B | PV/CO | Good tolerance | – | – |
7 | B | PV/CO | Good tolerance | – | – |
8 | B | PV | Anaphylaxis | 45 | 150 |
CO | Good tolerance | – | – | ||
9 | A | PV/CX/CO | Good tolerance | – | – |
10 | A | PV/CX/CO | Good tolerance | – | – |
11 | A | PV/CX/CO | Good tolerance | – | – |
12 | B | PV/CO | Good tolerance | – | – |
13 | A | PV/CX/CO | Good tolerance | – | – |
14 | A | PV/CX/CO | Good tolerance | – | – |
15 | A | PV/CX/CO | Good tolerance | – | – |
16 | B | PV/CO | Good tolerance | – | – |
17 | A | PV/CX/CO | Good tolerance | – | – |
18 | A | PV/CX/CO | Good tolerance | – | – |
19 | A | AX | Urticaria | 140 | 500 |
PV/CX/CO | Good tolerance | – | – | ||
20 | B | PV/CO | Good tolerance | – | – |
21 | B | PV/CO | Good tolerance | – | – |
22 | A | CX/CO | Good tolerance | – | – |
23 | B | CO | Good tolerance | – | – |
24 | A | PV/CX/CO | Good tolerance | – | – |
25 | B | PV/CO | Good tolerance | – | – |
26 | A | AX | Generalized pruritus and erythema | 60 | 150 |
PV/CX/CO | Good tolerance | – | – | ||
27 | A | PV/CO | Good tolerance | – | – |
28 | A | PV/CX/CO | Good tolerance | – | – |
29 | A | PV/CX/CO | Good tolerance | – | – |
30 | A | PV/CX/CO | Good tolerance | – | – |
31 | B | PV/CO | Good tolerance | – | – |
32 | B | PV/CO | Good tolerance | – | – |
33 | A | PV/CX/CO | Good tolerance | – | – |
34 | B | PV | Good tolerance | – | – |
CO | Urticaria | 25 | 50 | ||
35 | B | CO | Good tolerance | – | – |
36 | A | PV/CX/CO | Good tolerance | – | – |
37 | B | PV/CO | Good tolerance | – | – |
CX | Urticaria | 50 | 150 | ||
38 | B | PV/CO | Good tolerance | – | – |
39 | B | PV/CX/CO | Good tolerance | – | – |
40 | A | PV/CX/CO | Good tolerance | – | - |
41 | A | PV/CX/CO | Good tolerance | – | - |
42 | A | PV/CX/CO | Good tolerance | – | – |
43 | A | PV/CX/CO | Good tolerance | – | – |
44 | A | PV/CX/CO | Good tolerance | – | – |
45 | A | PV/CX/CO | Good tolerance | – | – |
46 | A | PV/CX/CO | Good tolerance | – | – |
47 | A | CX/CO | Good tolerance | – | – |
48 | A | CX/CO | Good tolerance | – | – |
49 | A | PV/CX/CO | Good tolerance | – | – |
50 | A | PV/CX/CO | Good tolerance | – | – |
51 | A | PV/CX/CO | Good tolerance | – | – |
52 | A | PV/CX/CO | Good tolerance | – | – |
53 | B | PV/CO | Good tolerance | – | – |
CX | Anaphylaxis | 30 | 50 | ||
54 | A | PV/CX/CO | Good tolerance | – | – |